COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge리툭시 맙 후 B 세포 고갈 된 환자의 Covid-19 : 진단 및 치료 문제Review Published on 2021-11-032022-08-31 Journal: Frontiers in Immunology [Category] MERS, SARS, 바이오마커, 진단, [키워드] adaptive Adaptive immunity Affect anti-CD20 anti-CD20 therapy anti-CD20 treatment anti-SARS-CoV-2 anti-SARS-CoV-2 monoclonal antibodies Antiviral treatment association Autoimmune disorders B cell B cell immunodeficiency B cell-depletion challenge Course COVID-19 deficiencies diagnostics disease Effect exposure to function hematologic hyperimmune convalescent plasma immune Immunity Immunotherapy Impact Interpretation involved long term malignancies Measures Musculoskeletal Protective rituximab SARS-CoV-2 SARS-COV-2 infection serological significantly Therapeutic approach therapeutic strategy vaccine responses variety [DOI] 10.3389/fimmu.2021.763412 PMC 바로가기 [Article Type] Review